Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Ay

Showing results (241-250 of 344) with videos related to

Pageof 35
Sort By:
Cancers|April 3, 2021
Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular CoagulationLena Hell, Thomas Däullary, Vanessa Burghart, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2025
External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: Results from the RIETE registryTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
The European Respiratory Journal|December 11, 2020
Clinical characteristics and 3-month outcomes in cancer patients with incidental <i>versus</i> clinically suspected and confirmed pulmonary embolismMarisa Peris, Juan J López-Nuñez, Ana Maestre, et al.
Thrombosis Research|July 13, 2023
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Serdar Farhan, Matthias K Freynhofer, et al.
Blood Advances|October 23, 2020
Association of ABO blood group with bleeding severity in patients with bleeding of unknown causeDino Mehic, Stefanie Hofer, Christof Jungbauer, et al.
Rheumatology (Oxford, England)|October 7, 2020
Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individualsLisa-Marie Mauracher, Moritz Krall, Johanna Roiß, et al.
Journal of Thrombosis and Haemostasis : JTH|September 19, 2025
Walking capacity and venous claudication after deep vein thrombosis: prospective follow-up, risk factors, and quality of lifeDaniel Steiner, Stephan Nopp, Timothy Hoberstorfer, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2025
Longitudinal dynamics of hemostatic biomarkers in patients with cancer receiving immune checkpoint inhibitors vs chemotherapy: results from the Vienna CAT-BLED studyNikola Vladic, Cornelia Englisch, Julia Maria Berger, et al.
Blood Advances|November 30, 2021
Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donorsHelmut Schweiger, Judit Rejtő, Christoph J Hofbauer, et al.
JACC. Advances|August 23, 2025
Variation in Venous Thromboembolism Outcomes Based on Primary Cancer Site: A RIETE Registry AnalysisJavier Trujillo-Santos, Cihan Ay, Behnood Bikdeli, et al.
Pageof 35

Showing results (241-250 of 344) with videos related to

Sort By:
Pageof 35
Cancers|April 3, 2021
Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular CoagulationLena Hell, Thomas Däullary, Vanessa Burghart, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2025
External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: Results from the RIETE registryTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
The European Respiratory Journal|December 11, 2020
Clinical characteristics and 3-month outcomes in cancer patients with incidental <i>versus</i> clinically suspected and confirmed pulmonary embolismMarisa Peris, Juan J López-Nuñez, Ana Maestre, et al.
Thrombosis Research|July 13, 2023
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Serdar Farhan, Matthias K Freynhofer, et al.
Blood Advances|October 23, 2020
Association of ABO blood group with bleeding severity in patients with bleeding of unknown causeDino Mehic, Stefanie Hofer, Christof Jungbauer, et al.
Rheumatology (Oxford, England)|October 7, 2020
Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individualsLisa-Marie Mauracher, Moritz Krall, Johanna Roiß, et al.
Journal of Thrombosis and Haemostasis : JTH|September 19, 2025
Walking capacity and venous claudication after deep vein thrombosis: prospective follow-up, risk factors, and quality of lifeDaniel Steiner, Stephan Nopp, Timothy Hoberstorfer, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2025
Longitudinal dynamics of hemostatic biomarkers in patients with cancer receiving immune checkpoint inhibitors vs chemotherapy: results from the Vienna CAT-BLED studyNikola Vladic, Cornelia Englisch, Julia Maria Berger, et al.
Blood Advances|November 30, 2021
Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donorsHelmut Schweiger, Judit Rejtő, Christoph J Hofbauer, et al.
JACC. Advances|August 23, 2025
Variation in Venous Thromboembolism Outcomes Based on Primary Cancer Site: A RIETE Registry AnalysisJavier Trujillo-Santos, Cihan Ay, Behnood Bikdeli, et al.
Pageof 35